In 2009, the U.S. Supreme Court in Wyeth v. Levine held that brand-name drug manufacturers are responsible for their warning labels and may be liable for not adding additional warnings when new risks are discovered. However, in 2011, the Supreme Court held that failure-to-warn claims brought against generic drug makers […]
Category: Defective Drugs
Paxil (paroxetine) is a drug widely prescribed to treat depression. In women fighting breast cancer it is not uncommon to be prescribed Paxil. The newest research should cause health practitioners to give that practice a second thought. A team of California researchers developed a drug screening method which they applied […]
Do we really need a new highly addictive opioid analgesic on the market to treat chronic pain, especially considering the high rates of drug addiction in the U.S? The drug Zohydro is set to be marketed come March and its approval is sparking a firestorm from consumer, drug addiction and […]
The common wisdom is that all drugs deliver a side effect as they deliver relief. The assumption has been that over-the-counter medications (OTC), used by millions of Americans, deliver fewer side effects – but that may not be true. Medications such as Aleve and Advil are getting a second review by […]
You’ve seen the ads on television. With just a dab of testosterone (T) gel under one’s arm, men can have their hormone levels restored as well as their sex drive, muscles, energy, hair, whatever has declined as they age. But a new study shows the practice of turning back time […]
Are men and women affected the same by the same dose of a drug? It turns out that the answer to that question for some drugs is no, and the Food and Drug Administration understood that for the sleeping aid Ambien as far back as 1992. CBS’s 60 Minutes tackled the issue […]
Spoliation of evidence has been defined by the courts as “the destruction or significant alteration of evidence, or the failure to preserve property for another’s use as evidence in pending or reasonably foreseeable litigation.” The concept behind this word defies one of the basic tenants in our legal system – […]
Johnson & Johnson is no longer on the hook to pay the state of Louisiana $257.7 million for the way it marketed the antipsychotic drug Risperdal. At the end of January, the Louisiana Supreme Court overturned a 2012 appeals court verdict which said J&J was liable for deceptive marketing. In […]
Despite all the company assurances that the anticoagulant Pradaxa is a superior alternative to warfarin, the Food and Drug Administration (FDA) plans to once again compare the two. Pradaxa was approved in 2010 but has since then brought a high complication rate to its users – including dangerous and uncontrolled bleeding […]
A trio of studies published in the Journal of the American Medical Association (JAMA) finds that just because a drug or medical device makes it to market does not necessarily mean it’s been tested and is safe and effective beyond all doubt. According to three published reviews, the same standards […]
